Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

16th Jun 09

Release Date: 16/06/2009 12:00am

Pharmaceutical company Pharmaxis (ASX:PXS, Nasdaq:PXSL) is pleased to announce that
additional results of its recently completed international Phase III trial of Bronchitol in patients
with cystic fibrosis have been presented at the 2009 European Cystic Fibrosis Conference in
Brest, France.

Read full media release - pdf

Categories: News and Media